Medicare and Medicaid Enrollees in Many High-Need Areas May Lack Access to Medications for Opioid Use Disorder

Date Issued

Wednesday, September 18, 2024

Submitting OIG

Department of Health & Human Services OIG

Agencies Reviewed/Investigated

Department of Health & Human Services

Report Number

OEI-BL-23-00160

Report Type

Inspection / Evaluation

Agency Wide

Yes

Number of Recommendations

Questioned Costs

Funds for Better Use

Report updated under NDAA 5274

External Link

Open Recommendations

This report has 4 open recommendations.

Recommendation Number	Significant Recommendation	Recommended Questioned Costs	Recommended Funds for Better Use
24-E-BL-035.01	No	$0	$0
CMS should geographically target efforts to increase the number of MOUD providers that treat Medicare enrollees in high-need counties.
24-E-BL-035.02	No	$0	$0
CMS should work with States to assess whether their Medicaid reimbursement rates for treatment with MOUD are sufficient to recruit and retain enough MOUD providers.
24-E-BL-035.03	No	$0	$0
CMS should work with SAMHSA to develop and maintain a list of active office-based buprenorphine providers.
24-E-BL-035.04	No	$0	$0
CMS should geographically target efforts to increase the number of MOUD providers that treat Medicaid enrollees in high-need counties.